m+Medelevator.RU
← Поиск публикаций
Frontiers in oncology · 2025

Deep learning based on MRI for assessing the prognostic value of lateral lymph nodes in rectal cancer.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Qiao Guanzhong, Feng Lili, Li Zhenhui, Wu Qiong, Liu Yulin, Zhao Jie, Jiang Hao, Zhao Ke, Cui Yanfen, Jiang Huijie

Аннотация

OBJECTIVES: Accurate preoperative evaluation of positive lateral lymph node (LLN) is crucial for optimizing treatment strategies in rectal cancer. Traditional methods, such as MRI T2-weighted imaging (T2WI), face limitations like interobserver variability and difficulty detecting small or occult metastases. Deep learning (DL) may provide a more efficient and precise alternative.

METHODS: In this multicenter, retrospective study, images from 1,000 patients across five centers were annotated to train a DL model for identifying and segmenting LLN. The model was tested on images from 480 patients in a validation cohort. Kaplan-Meier analysis compared disease-free survival (DFS) and overall survival (OS) between LLN-positive and LLN-negative groups, while Cox regression identified prognostic factors for DFS and OS.

RESULTS: The DL model achieved an accuracy of 87.5% and a specificity of 73.8% in predicting LLN positivity, demonstrating high diagnostic performance. Both univariate and multivariate Cox regression analyses identified LLN status, circumferential resection margin (CRM), and tumor downstaging (TD) as independent prognostic factors. Kaplan-Meier analysis showed patients with positive LLNs had worse outcomes, with 3-year DFS of 57.66% vs. 81.66%, and 5-year OS of 61.62% vs. 84.82% compared to LLN-negative patients.

CONCLUSIONS: The DL model effectively predicts positive LLNs, offering an efficient alternative to traditional methods and supporting preoperative decision-making. Its clinical implementation could enhance risk stratification and personalize therapeutic strategies for rectal cancer patients.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты